{{Rsnum
|rsid=12095080
|Gene=DIO1
|Chromosome=1
|position=53911057
|Orientation=plus
|GMAF=0.09458
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=DIO1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 82.1 | 16.1 | 1.8
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 60.5 | 34.7 | 4.8
| ASW | 57.1 | 41.1 | 1.8
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 86.1 | 12.9 | 1.0
| LWK | 67.3 | 30.0 | 2.7
| MEX | 87.9 | 12.1 | 0.0
| MKK | 76.9 | 22.4 | 0.6
| TSI | 77.5 | 21.6 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21715540
|Title=The Type 2 Deiodinase ORFa-Gly3Asp Polymorphism (rs12885300) Influences the Set Point of the Hypothalamus-Pituitary-Thyroid Axis in Patients Treated for Differentiated Thyroid Carcinoma
}}

{{PMID Auto
|PMID=18815314
|Title=Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}